Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 13/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9726212 | 1.00 | SIGMAR1 (0.49) | SIGMAR1HPGDTLR2MEN1KMT2A | |
| SCHEMBL8534426 | 0.85 | CNR1 (0.44) | SIGMAR1 | |
| SCHEMBL9044382 | 0.84 | CNR1 (0.47) | SIGMAR1 | |
| SCHEMBL4314476 | 0.82 | SIGMAR1 (0.56) | SIGMAR1MEN1KMT2A | |
| SCHEMBL8340029 | 0.82 | SIGMAR1 (0.56) | SIGMAR1MEN1KMT2A | |
| SCHEMBL11228655 | 0.79 | SIGMAR1 (0.41) | SIGMAR1 | |
| SCHEMBL3464964 | 0.77 | SIGMAR1 (0.77) | SIGMAR1 | |
| SCHEMBL8530955 | 0.77 | FAAH (0.55) | MEN1KMT2A | |
| SCHEMBL9303452 | 0.76 | LTA4H (0.45) | SIGMAR1 | |
| SCHEMBL28469500 | 0.76 | FAAH (0.54) | HPGDTLR2BCHENAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5811391-A | INHIBITS BINDING BETWEEN THE VLA-4 RECEPTOR EXPRESSED ON INFLAMMATORY LEUKOCYTES AND A FIBRONECTIN; ANTIINFLAMMATORY AND-ARTHRITIC AGENTS; ASTHMA; OLIGOPEPTIDES | CYTEL CORPORATION (US) | 1998-09-22 | — | — | US | claimed |
| EP-0777681-A2 | CYCLIC CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME | CYTEL CORPORATION (US) | 1997-06-11 | — | — | EP | claimed |
| WO-1996006108-A2 | CYCLIC CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME | CYTEL CORPORATION (US) | 1996-02-29 | — | — | WO | claimed |
| US-5869448-A | INHIBIT BINDING BETWEEN VLA-4 RECEPTOR AND FIBRONECTIN CS-1 PEPTIDES; TREATING IMMUNOINFLAMMATORY CONDITIONS | CYTEL CORPORATION (US) | 1999-02-09 | — | — | US | disclosed |
| US-5811391-A | INHIBITS BINDING BETWEEN THE VLA-4 RECEPTOR EXPRESSED ON INFLAMMATORY LEUKOCYTES AND A FIBRONECTIN; ANTIINFLAMMATORY AND-ARTHRITIC AGENTS; ASTHMA; OLIGOPEPTIDES | CYTEL CORPORATION (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0777681-A2 | CYCLIC CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME | CYTEL CORPORATION (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996006108-A2 | CYCLIC CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME | CYTEL CORPORATION (US) | 1996-02-29 | — | — | WO | disclosed |